Resveratrol
What the European Food Safety Authority and the United States National Institutes of Health have published about resveratrol intake, and what the catalogue records. Reference figures and citations only.
Stacky is an organisational tool, not a medical device. It does not provide medical advice, and nothing on this page says what resveratrol does. Talk to a doctor or pharmacist before starting, stopping or changing what you take.
Published intake references
Each figure is one authority’s published value, with the kind of figure and the people it applies to as that authority stated them. Where the EU and the US differ, both are shown and neither is averaged or converted. Only a tolerable upper intake level sets a ceiling. A recommended or adequate intake is context, not a limit.
EUEuropean Union — EFSA
USUnited States — NIH ODS / IOM
“None established” means that authority examined resveratrol and set no upper limit. What it published instead is below, with its own label.
Also published, and not a limit
These are the authority’s own words for a figure that is not a tolerable upper intake level. The app never compares a dose against one; this page prints it because the authority did.
To cite a figure, cite the authority’s document linked on its card, and this page as where you read it: stacky-app.com/substances/resveratrol, retrieved 13 November 2026. Every card has its own address: add #eu-none_established-1 to the page URL for the first one.
Products in Stacky’s catalogue containing Resveratrol
1 product whose label declares resveratrol, listed by brand and drawn as the app draws them. Amounts are the manufacturer’s printed figures; Stacky has measured nothing and ranks nothing.
How it is recorded
What the app records so it can schedule a dose. None of it is advice.
Default food note in the app: with food.
Indexed studies
A study reaches this page only if its own title names Resveratrol or one of its recorded alternative names, and does not name a disease or clinical condition. The second rule removes papers that are about resveratrol; a title naming a condition beside a substance reads as a claim, and this page makes none. Titles are the studies’ own words, newest first. A study being listed is not a statement that resveratrol does what it set out to test. How this list is built →
| Title | Journal | Year | Reference |
|---|---|---|---|
| Resveratrol and Its Effects on the Vascular System. | Int J Mol Sci | 2019 | PubMed 30934670 |
Showing 1 of the 5 papers indexed against resveratrol in Stacky.
About this page
Stacky is a supplement tracking app. It renders what you take and what published sources say about it; it does not tell you what to take. Every figure on this page names the authority that published it and links to that authority’s own page.
Not on this page: a dose of our own, a grade, a verdict on whether resveratrol works, or any statement that it treats, prevents or improves a condition. How these pages are built →
Figures are read from the authorities’ published tables and can go out of date when those tables are revised. If one here is wrong, tell us at support@stacky-app.com and we will check it against the source.